Skip to content

The Role of Telemedical Monitoring in Diabetic Foot Ulcer Care

The Role of Telemedical Monitoring in Diabetic Foot Ulcer Care

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02818322
Acronym
A15-06
Enrollment
150
Registered
2016-06-29
Start date
2016-04-30
Completion date
2018-10-31
Last updated
2016-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot - Telemedical Monitoring

Brief summary

The role of telemedical monitoring in diabetic foot care is still uncertain. The aim is to compare telemedical + standard and standard alone outpatient monitoring in the care of patients with diabetic foot ulcers in a randomized controlled trial. The primary outcome of the overall study is the time of ulcer healing. The number of amputation, hospital admissions and surgical procedure will be also reported. Investigators hope to include 150 patients in this study.

Interventions

DEVICEtelemedical monitoring ( T)
DEVICEclassic monitoring

Sponsors

CHU de Reims
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patients treated in the diabetology department of CHU de Reims during the inclusion phase to a diabetic foot lesions ( infected or not). * Patients with care of this lesion of diabetic foot externally. * Patients who agreed to participate in or accepting ORNICARE network ( network for the transmission of information between health care professionals) (Appendix 3) . * Patients aged over 18 years . * Patients who agreed to participate in the study . * The patients insured by a social security scheme .

Exclusion criteria

* Patients requiring hospital care of the lesion of diabetic foot (infection requiring surgical intervention , ischemia requiring revascularization , ...). * Patients are protected by law . * Minor patients.

Design outcomes

Primary

MeasureTime frame
time of ulcer healing6 month after inclusion

Countries

France

Contacts

Primary ContactMaud FRANCOIS
mfrancois@chu-reims.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026